Farmakoterapia w Psychiatrii i Neurologii

Full text

1/2024 vol. 40
Case report

Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reports

Isabella Nizińska 1
,
Karolina Gattner 1
  1. HCP Medical Centre; Centrum Zdrowia Psychicznego HCP
Farmakoterapia w Psychiatrii i Neurologii 2024, 40 (1), 53–60
DOI: https://doi.org/10.5114/fpn.2024.141961
Data publikacji online: 2024/08/01
Article file
06_IPiN_FARM_2024-1E_Zatrucie litem.pdf
  1. Adityanjee. The syndrome of irreversible lithium effectuated neurotoxicity. J Neurol Neurosurg Psychiatry. 1987; 50(9): 1246–7.
  2. Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium Poisoning. J Intensive Care Med 2017; 32(4): 249–63.
  3. Bisogni V, Rossitto G, Reghin F, Padrini R, Rossi GP. Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders. J Hypertens 2016; 34 (1): 20–8.
  4. Edokpolo O, Fyyaz M. Lithium toxicity and neurologic effects: probable neuroleptic malignant syndrome resulting from lithium toxicity. Case Rep Psychiatry 2012; 2012: 271858. doi:10.1155/2012/271858.
  5. Finley PR, O’Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol 1996; 16(1): 68–71.
  6. Lazarczyk MJ, Giannakopoulos P. Temporal association as a prerequisite factor of valsartan-induced lithium toxicity. Bipolar Disord 2014; 16(6): 662–6.
  7. Leung M, Remick RA. Potential drug interaction between lithium and valsartan. J Clin Psychopharmacol 2000; 20(3): 392–3.
  8. Meyer JM, Dollarhide A, Tuan IL. Lithium toxicity after switch from fosinopril to lisinopril. Int Clin Psychopharmacol 2005; 20(2): 115–118.
  9. Momoniat T, Ilyas D, Bhandari S. ACE inhibitors and ARBs: Managing potassium and renal function. Cleve Clin J Med 2019; 86 (9): 601–607.
  10. Ott M, Stegmayr B, Salander Renberg E, Werneke U. Lithium intoxication: Incidence, clinical course and renal function – a population-based retrospective cohort study. J Psychopharmacol 2016; 30 (10): 1008–1019.
  11. Rybakowski J. Lit. Niezwykły lek w psychiatrii. Termedia Wydawnictwa Medyczne, wyd. 1, Poznań 2019.
  12. Rybakowski J. Psychofarmakologia kliniczna. Wydawnictwo Lekarskie PZWL, wyd. 1, Warszawa 2022.
  13. Scherf-Clavel M, Treiber S, Deckert J, Unterecker S, Hommers L. Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs. Pharmacopsychiatry 2020; 53(5): 229–234.
  14. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging 2000; 16(3): 165–177.
  15. Su YP, Chang CJ, Hwang TJ. Lithium intoxication after valsartan treatment. Psychiatry Clin Neurosci. 2007; 61(2): 204.
  16. Tursun I, Tazegul G, Karhan O, et al. Polypharmacy May Be the Cause of Acute Lithium Intoxication at the Second Day of Treatment. Folia Med (Plovdiv) 2015; 57(3–4): 261–263.
  17. Wilting I, Movig KL, Moolenaar M, et al. Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disord 2005; 7(3): 274–280.
  18. Zwanzger P, Marcuse A, Boerner RJ, Walther A, Rupprecht R. Lithium intoxication after administration of AT1 blockers. J Clin Psychiatry 2001; 62(3): 208–20
SUBMIT YOUR PAPER
Share
without publication fees
without publication fees
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications